chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient has had pain and numbness at vaccine site since it was given.  She has used heat and ice off and on the last 3 months.  Pain is radiating up into her shoulder.  Still feels sore when she touches injection site.  She reports that she has even felt numbness in her arm down to her fingertips at times.  She saw a chiropractor last week and states he said it is just inflammation.  She did not provide any specific dates.
Moderna COVID-19 Vaccine EUA Symptoms: Headache, fever of 102.7, chills, nausea, vomiting, shaking, stomach pains, tinder arm at injection site, all over body aches and pains.
Information has been received from a female who was vaccinated with a dose of pneumococcal vaccine 23 polyvalent (site and dose not reported). Subsequently the pt's arm swelled up and was red. The pt sought unspecified medical attention. Additional info has been requested.
Patient was given half a dose (booster dosage) as his second dose.  Patient will likely come back to receive the other half of the dose.
Constant crying and fever of 102F to 103.5F for 48 hours.
Within 10 minutes of vaccination patient developed urticaria and small, pink blanchable macules. First noticed on (R) arm with what more appeared as a local reaction. The diffuse truncal rash occurred. Given BENADRYL and improved.
Pt received flu shot and while leaving the store he fainted but did not sustain injury. Followed up with patient later on and he was fine. Addressed patient's concerns.
mild case of shingles; This case was reported by a consumer and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was recovering/resolving.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the first dose of Shingrix. Prior to receiving the 2nd dose, the patient developed a mild case of shingles which had almost but not quite resolved. the patient's deadline (6 months) for the 2nd shot is a week away. The patient had a concern that, should they go ahead with the 2nd dose? Patient's primary care Dr. was uncertain. If the patient's didn't get the 2nd dose, do they start over when they shingles was completely resolved.
I work up at around 7:45 am on Monday, 2/8, and around 8am I began feeling nauseous, having a headache, a funny taste in my mouth, and feeling out of breath
Pt received his first PNEUMOVAX around 1030 AM on 9/17/13. By 1500 same day he broke out in hives all over (worst on trunk) and flushing of face with extreme itching. Took BENADRYL and CLARITIN.
2 year old Bexsero; This case was reported by a consumer via interactive digital media and described the occurrence of inappropriate age at vaccine administration in a 2-year-old patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received the 1st dose of Bexsero and Bexsero Pre-Filled Syringe Device. On an unknown date, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The reporter was the patients parent. The patient received dose of Bexsero at the age of 2 years old, which led to inappropriate age at vaccine administration. The reporter stated that, forgot to give 2nd dose of Bexsero to the patient. The reporter asked if start again with 2 doses.
Small red mark same day of vaccine; A spontaneous report was received from a consumer concerning a 80-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events small red spot, the mark resurfaced and had grown in size to approximately 6 inches in length and 3 inches in width (vaccination site erythema).  The patient's medical history was not reported.  The patients current condition include Parkinson's disease.  Concomitant medications reported were Acetylsalicylic Acid.  On 25 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 25 Jan 2021, the patient experienced the event- small red spot, On 2 Feb 2021, the patient experienced the events  the mark resurfaced and had grown in size to approximately 6 inches in length and 3 inches in width.  The treatment details included Sarna lotion.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event vaccination site erythema was unknown.; Reporter's Comments: Based on the information provided, a strong temporal association and the established safety profile of mRNA-1273 vaccine, a causal association between the reported events and the product use cannot be excluded. vaccination site erythema is consistent with the known safety profile of the vaccine.
PT RECEIVED Pfizer-BioNTech COVID-19 Vaccine. During observation period, pt felt as though her tongue was "thick" and her lips were tingling. Pt took a Claritin Ready Melt 10 mg tablet and sat under observation for addition 30 minutes. Symptoms subsided and pt left pharmacy area. She will carry her Epi-Pen with her for the next couple days.
Patient inadvertently received a pediarix vaccine instead of dtap; This case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 16-month-old male patient who received DTPa-HBV-IPV (Pediarix) (batch number 9X325, expiry date 5th March 2023) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 5th May 2022, the patient received Pediarix and Pediarix Pre-Filled Syringe Device. On 5th May 2022, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered. On an unknown date, the outcome of the wrong vaccine administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 05-MAY-2022 Reporters comment: The patient inadvertently received Pediarix vaccine instead of dtap in left thigh. The reporter consented to follow up. Additional supportive information: The patient inadvertently received Pediarix vaccine instead of dtap, which led to wrong vaccine administered.
I had both the Covid shot and a flu shot a little bit later. I?ve had some soreness in my chest feels like bruised ribs but over my center of my chest. This morning I woke up on the right side of my face which is the same side that the rib/chest soreness is on is tender and sore to the touch on my right side underneath my eye. This is a long with fatigue and arm soreness
Pt woke up day after vaccine not feeling well, ran fever for several days, then rash showed up 5 days later and they went to ER.
Patient called Thursday around 2 pm and asked if it was normal to hurt all over.  I told her muscle pain could be an adverse effect.  The patient then said she felt that her blood pressure was up and felt as though a mack truck was on her chest.  I instructed her to go to the ER.
This spontaneous report was received from a pharmacy intern referring to unspecified number of patient of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On an unknown dates since 07-JUL-2016, the patients were vaccinated with improperly stored doses of ZOSTAVAX which had lot # L029484 with expiry date: 06-NOV-2016 and lot# M010472 with expiry date: 01-JUN-2017 (dosing details not provided). The vaccine was exposed to a temperature of 36 degree Fahrenheit for 22 hours. The vaccine had no previous temperature excursion. The call was due to data logger. No adverse effects and no product quality complaint (PQC) reported. No further information provided. This is one of two reports received from the same reporter. Additional information has been requested.
mom reported to RN that pt had inconsolable screaming for 7 hrs p/inject given;
patient received Pfizer COVID Vaccine (LOT EL3302, EXP 05/2021)  after checking in to Vaccine site after 0758 .  After receiving vaccine patient went to Auditorium for post injection observation period.  Within a few  minutes,  patient's wife yelled out for help.  Nurse responded and stated patient was pale, limp and unresponsive.  Epi Pen #1 was administered, with no response.  Epi Pen #2 was then administered,  patient immediately jumped up, alert and oriented immediately after receiving second Epi Pen. Code was called at 0814 and patient was transported to Emergency Department by Code team.
Patient was given vaccine (Pfizer Biotech) around 1:00 pm on 07/29/2022, got up from chair and stood for a moment. Patient turned pale, blacked out and feel forward. Patient quickly come to and in 15 mins was back to normal
After about 3 hours, a wave of dizziness and lightheadedness occurred. The injection site was very sore.  Slept for about 3 hours day of the vaccine. The next morning, dizziness and lightheadedness were gone. The arm is still a bit sore, but more manageable.
Fatigue starting at 6pm day of injection, followed shortly by chills and aches. 11pm chills and aches continued with a fever of 100 even after taking Tylenol. Nausea and vomiting continued through the night. Tylenol has been dosed every 6 hours, chills and aches have continued. Fever has been steady around 99 even with Tylenol. Migraine began day after vaccine around 6am and has continued through the day.
Was given a pfizer vaccination in April 2020, came to our office last week and told us they needed their 2nd dose and that it was Moderna. After leaving the office we discovered she had one of both vaccines. No side effects reported.
This spontaneous report as received from a certified medical assistant refers to unspecified number of patients of unknown age and gender. Pertinent medical history and concomitant therapies were not provided. On unknown dates, the patients were administered improperly stored doses of oral ROTATEQ (lot # K023534, expiry date 22-MAY-2016, orally, dose not reported). No adverse experiences were reported. This is one of several reports from the same reporter. Additional information has been requested.
lower back muscle pain/ lower back hurt; feeling very weak/ really weak; very sore throat; lower back muscle pain/ pain in muscles; pain in muscles and in her arm her left arm; left arm was feeling very weak; not feeling well/ felt sick; pain in her whole body; felt bad; strong aches under her armpit and on the left breast; strong aches under her armpit and on the left breast; This is a spontaneous report received from contactable consumer from medical information team. The reporter is the patient.   A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administered in the left arm, administration date 24Mar2021 11:00 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BACK PAIN (non-serious) with onset Mar2021, outcome "unknown", described as "lower back muscle pain/ lower back hurt"; ASTHENIA (non-serious) with onset Mar2021, outcome "unknown", described as "feeling very weak/ really weak"; OROPHARYNGEAL PAIN (non-serious) with onset Mar2021, outcome "unknown", described as "very sore throat"; MYALGIA (non-serious) with onset Mar2021, outcome "unknown", described as "lower back muscle pain/ pain in muscles"; PAIN IN EXTREMITY (non-serious) with onset Mar2021, outcome "unknown", described as "pain in muscles and in her arm her left arm"; MUSCULAR WEAKNESS (non-serious) with onset Mar2021, outcome "unknown", described as "left arm was feeling very weak"; MALAISE (non-serious) with onset Mar2021, outcome "unknown", described as "not feeling well/ felt sick"; PAIN (non-serious) with onset Mar2021, outcome "unknown", described as "pain in her whole body"; FEELING ABNORMAL (non-serious) with onset Mar2021, outcome "unknown", described as "felt bad"; AXILLARY PAIN (non-serious), BREAST PAIN (non-serious) all with onset Mar2021, outcome "unknown" and all described as "strong aches under her armpit and on the left breast". The events "lower back muscle pain/ lower back hurt", "feeling very weak/ really weak", "very sore throat", "lower back muscle pain/ pain in muscles", "pain in muscles and in her arm her left arm", "left arm was feeling very weak", "not feeling well/ felt sick", "pain in her whole body", "felt bad", and "strong aches under her armpit and on the left breast" were evaluated at the physician office visit. Therapeutic measures were taken as a result of back pain, asthenia, oropharyngeal pain, myalgia, pain in extremity, muscular weakness, malaise, pain, feeling abnormal, axillary pain, breast pain.  Additional information: The patient's age was reported as 66 (unit unspecified). She went to gastroenterology and was told to take paracetamol (TYLENOL).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Large asymmetrical rash appeared next day 7/8. Red, hot to touch, swole , very painful.  Day 7/9: same symptoms, but worse. Rash was larger,  and slightly itchy, very painful to touch.  7/10: redness stated to subside, still painful, slightly itchy. 7/11: symptoms lessening, but  tender; 7/12: mostly gone, slight pain still noticeable .  Was this a Type III Hypersensitivity or Allergic  Arthus Reaction? ?Covid arm??
Xeljanz XR is not as effective since she has taken the Pfizer Covid vaccine.; Patient advised she has Psoriasis; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 66 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: DRUG INTERACTION (non-serious), outcome "unknown", described as "Xeljanz XR is not as effective since she has taken the Pfizer Covid vaccine."; PSORIASIS (non-serious), outcome "unknown", described as "Patient advised she has Psoriasis".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Seen at hospital for chest pain and shortness of breath on 4/07/2021. Found to have NSTEMI
Initial information received on 25-Mar-2019 regarding an unsolicited valid non-serious case received from a non-healthcare professional via phone. This case involves a 16 years old female patient who experienced had arm pain for 2 days, stiff neck, also got a fever, feeling lousy, exhaustion and headache, while she received vaccine MENACTRA for type 2 diabetes mellitus (as reported). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications were not reported. On 19-Mar-2019 (Tuesday), the patient received a 0.5 ml first dose of suspect MENACTRA (lot number, expiry date and route of administration were not reported) in the left arm. On an unspecified date, the patient developed a non-serious had arm pain for 2 days, stiff neck, also got a fever, feeling lousy, exhaustion and headache following the administration of MENACTRA. No Lab data was reported. Final diagnosis was headache, exhaustion, feeling lousy, also got a fever, stiff neck and had arm pain for 2 days. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Not Recovered / Not Resolved on an unknown date for feeling lousy, as Unknown for exhaustion, stiff neck, headache, had arm pain and fever. Documents held by the sender: none.
Child was an anxious child but volunteered to be first for shot. Took the three shots well. About 10 minutes later, child looked like he might faint- no sweating. No pallor but I picked up child and laid him on table. Raised his legs and "he felt better". I kept him flat on the table. BP: 108/70 and P 86. Offered juice.
she has known two people to get the vaccine and 'drop dead'; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID: (159558).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death, medically significant), outcome "fatal", described as "she has known two people to get the vaccine and 'drop dead'". The date and cause of death for the patient were unknown.  Clinical information: Caller seeking where in her state of (State name), can she get the Comirnaty labeled vaccine. She stated she was being forced to get the vaccine or lose her job. She relays that she had known two people to get the vaccine and 'drop dead' she does not specify which Covid 19 vaccine these people have received.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received. Sender's Comments: Linked Report(s): PFIZER INC-202201202498 same reporter/drug/event, different patients; Reported Cause(s) of Death: she has known two people to get the vaccine and 'drop dead.'
Pt c/o itching, reddened and warm skin. 25 mg of Benadryl PO given
Itchiness; Redness as well as bruise at injection site; It is inflamed, 1 1/2 inch below the shot; Redness as well as bruise at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of DERMATITIS (It is inflamed, 1 1/2 inch below the shot), VACCINATION SITE BRUISING (Redness as well as bruise at the injection site), VACCINATION SITE PRURITUS (Itchiness) and VACCINATION SITE ERYTHEMA (Redness as well as bruise at injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included Eczema. Concomitant products included FAMOTIDINE (PEPCID [FAMOTIDINE]), VITAMINS NOS and WHITE SOFT PARAFFIN (AQUAPHOR [WHITE SOFT PARAFFIN]) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced DERMATITIS (It is inflamed, 1 1/2 inch below the shot), VACCINATION SITE BRUISING (Redness as well as bruise at the injection site) and VACCINATION SITE ERYTHEMA (Redness as well as bruise at injection site). On 21-Feb-2021 at 2:00 AM, the patient experienced VACCINATION SITE PRURITUS (Itchiness). The patient was treated with HYDROCORTISONE (CORTAID [HYDROCORTISONE]) in February 2021 at an unspecified dose and frequency. At the time of the report, DERMATITIS (It is inflamed, 1 1/2 inch below the shot), VACCINATION SITE BRUISING (Redness as well as bruise at the injection site), VACCINATION SITE PRURITUS (Itchiness) and VACCINATION SITE ERYTHEMA (Redness as well as bruise at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products included Lubber derma for an unknown indication.
Severe headaches starting a week after shot; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 11Apr2021 at 13:15 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis and interstitial lung disease. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN), mycophenolate mofetil (MYCOPHENOLATE), levothyroxine sodium (SYNTHROID) and prednisone (MANUFACTURER UNKNOWN); all from unknown date for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 21Mar2021 at 13:15 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. On 18Apr2021, the patient experienced severe headaches starting a week after shot. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe headaches starting a week after shot was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Skin lesions on the b/l hands -- 1st lesion on 1/9 morning: right mid 2nd digit, painful erythematous indurated, mildly pruritic, <1cm in diameter 2nd lesion came on 1/9 evening:  right 3rd digit proximally similar lesion as 1st 3rd &4th  lesions came on 1/10: left mid 2nd digit, left mid 3rd digit -- > mild relief of all lesions with OTC hydrocortisone cream, once daily on 1/15: right mid 2nd digit and right 3rd proximal: annular, erythema with central clearing with small erythema at the very center of the lesion, painful, papular, non scaly (looked like erythema multiform); left hand lesions evolved into 1cm erythematous papule 1/21: all lesions are 1cm erythematous painful papules
pt stated she immediately had a taste inside her mouth.  Her mouth became numb and she developed bumps like blisters on the inside of the mouth.  Pt contacted PCP and was told to go the ER if she got any worse.  So today 3/23/2021 she went to the Urgent Care.  She was given a steroid shot and prescribed famotidine 20mg x 2 days for 7 days. Pt still has these symptoms but waiting for the injection to help. Pt will FU w/ PCP.